Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Explore the clinical insights into lumateperone, a second-generation antipsychotic showing promise in treating schizophrenia, and learn how understanding effect sizes can guide your treatment decisions.
Psychiatry September 6th 2023
Discover the latest advancements in ADHD therapies that promise greater efficacy and fewer side effects—options that can revolutionize personalized treatment plans.
Internal Medicine September 6th 2023
Psych Congress Network
Explore how a paradigm shift from monoamine to GABAergic systems could offer new, more effective treatments for major depressive disorder; the latest review discusses the unmet needs and the promising potential of NAS GABAA receptor PAMs.
Addiction Professional
The alarming findings on nitazenes’ impact on cardiac arrest rates and naloxone dosage requirements demand your attention; further details could change how we approach opioid overdose treatments.
Emergency Medicine September 6th 2023
American Journal of Endocannabinoid Medicine (AJEM)
Learn more about how the HHS’s recommendation to reschedule marijuana could revolutionize research and impact your practice, offering more comprehensive treatment options for patients.
Family Medicine/General Practice September 6th 2023
Understanding the neural mechanisms behind emotional control in anxious individuals could offer new avenues for therapeutic interventions. Discover how a shift from FPl to dorsolateral prefrontal cortex may impact emotional regulation in anxiety disorders.
Neurology September 6th 2023